Phase 4 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to give informed consent following the study's consent process
- People who are willing to follow all study procedures throughout the trial
- People who have natural menstrual cycles that are regular, meaning they last between 21 and 35 days, consistently over the past 6 months
- People who have smoked at least 5 cigarettes per day every day for the past 6 months
- People who plan to quit smoking within the next 30 days and are willing to set a specific quit date as part of the study
- People who are interested in using nicotine patches and nicotine gum or lozenges as tools to help with quitting
- People who are willing to provide a valid email address for study communications and online questionnaires
Who may not be able to join:
- People currently using progesterone, estrogen, testosterone, or any fertility treatments
- People currently using nicotine replacement therapy or other quit-smoking medications such as varenicline or bupropion
- People who have used hormonal contraceptives in the past 6 months, including the pill, patch, hormonal IUD, or vaginal ring
- People who are pregnant or planning to become pregnant in the next 2 to 3 months
- People with a known allergy or sensitivity to any ingredient in the nicotine patch
- People who have used cannabis daily or almost daily in the past 6 months
- People who have used tobacco or nicotine products other than cigarettes — such as smokeless tobacco, heated tobacco, or e-cigarettes — daily or almost daily in the past 6 months
- People who have been diagnosed with polycystic ovary syndrome (PCOS)
- People with an unstable mental health condition or substance use disorder that could affect their ability to follow study procedures
- People with life-threatening heart rhythm problems or severe or worsening chest pain (angina)
- People who have had a heart attack or stroke in the past 2 weeks
- People who have been diagnosed with a terminal illness
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurie A Zawertailo, PhD, Centre for Addiction and Mental Health
Phone: 4165358501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
7-day point prevalence of abstinence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.